General Atlantic LLC
- SEC CIK
- 0001017645
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 14, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 15
- −1 vs. Q4 2024
- Portfolio value
- $2.98B
- +$169.7M (+6.0%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GROVGrove Collaborative Holdings, Inc. | COM CL A | 2,474,859 | $3.34M | 0.1% | 00.0% | Unchanged | History |
| LOGCContextLogic Holdings Inc. | CL A NEW | 609,616 | $4.26M | 0.1% | 00.0% | Unchanged | History |
| ADAGAdagene Inc. | ADS | 3,825,952 | $5.82M | 0.2% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 2,695,327 | $6.66M | 0.2% | 00.0% | Unchanged | History |
| RSKDRiskified Ltd. | SHS CL A | 5,324,998 | $24.6M | 0.8% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 1,261,684 | $37.4M | 1.3% | 00.0% | Unchanged | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 1,500,000 | $46.7M | 1.6% | 00.0% | Unchanged | History |
| EWCZEuropean Wax Center, Inc. | CLASS A COM | 13,110,492 | $51.8M | 1.7% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 7,531,252 | $118.2M | 4.0% | 00.0% | Unchanged | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 9,681,818 | $139.2M | 4.7% | 00.0% | Unchanged | History |
| AKROAkero Therapeutics, Inc. | COM | 5,233,989 | $211.9M | 7.1% | 00.0% | Unchanged | History |
| ALKTAlkami Technology, Inc. | Stock | 9,645,318 | $253.2M | 8.5% | 00.0% | Unchanged | History |
| XPXP Inc. | CL A | 29,617,733 | $407.2M | 13.7% | 00.0% | Unchanged | History |
| DLOdLocal Ltd | CLASS A COM | 63,906,695 | $533.0M | 17.9% | 00.0% | Unchanged | History |
| ALHCAlignment Healthcare, Inc. | COM | 60,993,323 | $1.14B | 38.1% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (1)
Positions held at the end of Q4 2024 that are gone from this filing.